WHO ICTRP trial

Study to Evaluate the Efficacy and Safety of VVZ-149 Injections for the…

KCT0010614 · Clinical Research Information Service (CRIS) · Not Recruiting

Key facts

Trial ID KCT0010614
Public title Study to Evaluate the Efficacy and Safety of VVZ-149 Injections for the Treatment of Low Back Pain
Scientific title A Phase 2, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of VVZ-149 Injections for the Treatment of Low Back Pain
Primary sponsor Asan Medical Center
Registry Clinical Research Information Service (CRIS)
Recruitment status Not Recruiting
Study type Interventional Study
Phase Phase2
Countries Korea, Republic of
Conditions Diseases of the musculoskeletal system and connective tissue
Interventions Drug : [VVZ-149 Treatment Group] VVZ-149 Injection (180 mg) will be mixed with normal saline and administered as an intravenous infusion over 30 minutes on Day 1 and Day 7. [Placebo Group] Placebo will be mixed with normal saline and…
Registration date Jun 10, 2025
Target size 60
Registry page cris.nih.go.kr

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations